Calum Robb: A Simplified Flow Cytometry Method for Measuring Human NETs
Calum Robb, Senior Key Account Manager at Thermo Fisher Scientific shared a post on LinkedIn about a recent article he and his colleagues co-authored:
“Proud to share our latest publication!
In this study, we developed a robust, flow cytometry–based assay to accurately quantify neutrophil extracellular traps (NETs), a key driver of inflammation in diseases ranging from autoimmunity to sepsis and cancer.
By using dual detection of DNA–Histone complexes, our method reliably distinguishes true NETosis from activation, apoptosis & necrosis, addressing a major challenge in the field.
- Sensitive
- Reproducible
- Scalable for routine lab use
We hope this provides a practical tool to advance NETosis research and support translational studies in inflammatory disease.
Massive thanks to all involved!”
Title: Simplified flow cytometric quantification of human neutrophil extracellular traps (NETs)
Authors: G. Rinaldi, K. K. W. Cheng, C. McCann, F. Rossi, M. Rodriguez-Rios, K. Dhaliwal, A. Bebes, L. Duncan, R. Yuecel, Adriano G. Rossi, Calum T. Robb
Read the Full Article on Journal of Inflammation

Stay updated with Hemostasis Today.
-
Aug 6, 2026, 01:21Orly Leiva: High-Output Heart Failure Signals Disease Progression in PV and ET
-
Aug 5, 2026, 23:46Recommended ESC Congress Sessions for the ESC Working Group on Thrombosis
-
Aug 5, 2026, 23:36Heghine Khachatryan: ISTH Day 2 – Phase III VAYHIT2 Data Highlights Ianalumab in Primary ITP
-
Aug 5, 2026, 23:28Basyouni Omran: KDIGO 2025/2026 Bedside Guide – Iron Correction in CKD
-
Aug 5, 2026, 23:13C. Michael Gibson: Jean Connors on Antithrombotic Therapy for LVAD at Baim Grand Rounds
-
Aug 5, 2026, 23:07Building Safer Systems for Bleeding and Clotting Care with Dr. Toyosi Onwuemene
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits